Improving insulin treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN79558333

Enrollment

Registered

2004-09-30

Start date

2003-04-22

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine: Diabetes Nutritional, Metabolic, Endocrine Insulin-dependent diabetes mellitus

Interventions

Randomised Controlled Trial 1. Glargine/novorapid/fasting and post-prandial titration of insulin doses 2. Glargine/novorapid/fasting and pre-prandial titration of insulin doses 30 patients with Type I

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Type 1 diabetes 2. >2 years duration 3. Clinical decision for glargine/novorapid therapy independently of the study 4. Fully informed and consented

Exclusion criteria

Exclusion criteria: Does not match inclusion criteria

Design outcomes

Primary

Measure	Time frame
To see if adjusting pre-prandial insulin on the basis of post-prandial measurements is feasible as a clinical approach in the routine clinical situation and to explore the possibility that it might improve overall diabetes control.	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026